CorporateInformation.com
 
Company Search:
Advanced Search
 
Sponsored Links
 
 
 
 
 
 
 
Biofrontera AG Company Snapshot
Biofrontera AG operates in the Pharmaceutical preparations sector. In addition to historical fundamental analyses, the complete report available to purchase compares Biofrontera AG with three other pharmaceutical manufacturers in Europe: Celon Pharma SA of POLAND (2020 sales of 139.27 million Polish New Zlotys [US$37.91 million] ), Camurus AB of SWEDEN (336.00 million Swedish Kronor [US$40.66 million] of which 96% was Sales of development related goods and s), and Circassia Group PLC which is based in UNITED KINGDOM (£23.90 million [US$33.76 million] of which 100% was operating-NIOX).

Sales Analysis. During the first quarter of 2021, sales at Biofrontera AG totalled 5.48 million Euro. This is a drop of 15.4% from the 6.47 million Euro in sales at the company during the first quarter in 2020. Biofrontera AG reported sales of 30.35 million Euro (US$36.96 million) for the year ending December of 2020. This represents a decrease of 2.9% versus 2019, when the company's sales were 31.27 million Euro.
   
   
 
Company ReportsSubscriptions
 
Looking For More?
Purchace an In-Depth Report
Biofrontera AG
  Stock Performance Chart for Biofrontera AG
 
  Stock Data: Recent Stock Performance:
  Current Price (6/4/2021): 2.93
(Figures in Euros )
1 Week -3.0%   13 Weeks 21.6%  
4 Weeks 16.7%   52 Weeks -15.7%  
 
Biofrontera AG Key Data:
  Ticker: B8F Country: Germany
  Exchanges: FRA Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Pharmaceutical Preparations
  2020 Sales 30,346,000
(Year Ending Jan 2021).
Employees: 149
  Currency: Euros Market Cap: 166,181,938
  Fiscal Yr Ends: December Shares Outstanding: 56,717,385
  Share Type: Stammaktie Closely Held Shares: 27,618,738
 
 
Sponsored Links
 
 
 
 
Feedback | Terms and Conditions | Privacy Policy | Site Index
 
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.